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epic3: revised recommendation for intravenous catheter and catheter site care 
Sir,  
In parallel with the National Institute for Health and Care Excellence (NICE) MTG 
review of Tegaderm 2% chlorhexidine gluconate (CHG) gel-impregnated dressing, the epic3 
scientific advisors reviewed the evidence and wording of the recommendation relating to the 
use of CHG-impregnated dressings, which currently states:1,2 
[Typesetter: small type below as indicated:] 
IVAD20 
Consider the use of a chlorhexidine-impregnated sponge dressing in adult patients with a central 
venous catheter as a strategy to reduce catheter-related bloodstream infection. 
New recommendation Class B 
Following a review of the evidence, the Guideline Development Group has revised the 
recommendation to include 2% CHG gel-impregnated dressings in addition to 2% CHG-
impregnated sponge dressings.3,4 The revised evidence summary and recommendation are 
given below. 
Revised evidence summary 
Catheter and catheter site care  
Infections can be minimized by good catheter and insertion site care  
The safe maintenance of an intravascular catheter and appropriate care of the insertion 
site are essential components of a comprehensive strategy for preventing catheter-related 
infections. This includes good practice in caring for the patient’s catheter hub and connection 
port, the use of an appropriate intravascular catheter site dressing regimen and using flush 
solutions to maintain the patency of the catheter.  
Choose the right dressing for insertion sites to minimize infection 
Following placement of a peripheral or central venous intravascular catheter, a 
dressing is used to protect the insertion site. Because occlusive dressings trap moisture on the 
skin and provide an ideal environment for the rapid growth of local microflora, dressings for 
insertion sites must be permeable to water vapour.5 The two most common types of dressings 
used for insertion sites are sterile, transparent, semi-permeable polyurethane dressings coated 
with a layer of an acrylic adhesive (‘transparent dressings’) and gauze and tape dressings. 
















The Healthcare Infection Control Practices Advisory Committee (HICPAC) reviewed 
the evidence related to which type of dressing provided the greatest protection against 
infection, including the largest controlled trial of dressing regimens on peripheral venous 
catheters (PVCs), a meta-analysis comparing the risk of catheter-related bloodstream 
infection (CR-BSI) using transparent versus gauze dressings and a Cochrane review.6‒9 All 
concluded that the choice of dressing can be a matter of preference but if blood is leaking 
from the catheter insertion site, a gauze dressing might be preferred to absorb the fluid. We 
identified an updated Cochrane review, which concluded that bloodstream infection was 
higher in the transparent polyurethane group when compared with gauze and tape.10 The 
included trials were graded low quality due to the small sample size and risk of bias. There 
was additional low quality evidence that demonstrated no difference between highly 
permeable polyurethane dressings and other polyurethane dressings in the prevention of 
catheter-related bloodstream infection. 
HICPAC reviewed the evidence related to impregnated sponge dressings compared to 
standard dressings and found two randomized controlled trials (RCTs) in adults that 
demonstrated 2% chlorhexidine-impregnated sponge dressings were associated with a 
significant reduction in CR-BSI.4,6,11 However, a meta-analysis that included eight RCTs 
found a reduction in exit site colonization but no significant reduction in CR-BSI.8 In 
paediatric patients, two small RCTs found a reduction in catheter colonization but not CR-
BSI, and evidence of localized contact dermatitis when used for infants of very low birth 
weight.12,13 
We identified one further systematic review and meta-analysis, undertaken as part of a 
quality improvement collaborative, which synthesized the effects of the routine use of 2% 
CHG-impregnated sponge dressings in reducing centrally inserted CR-BSI.14 Five studies 
were included in the analysis: two of the five studies were in patients in haemo/oncological 
intensive care units (ICUs); the remaining three were in surgical and medical ICUs; four of 
the five studies were sponsored by the manufacturer of the product. The reviewers concluded 
that 2% CHG-impregnated sponge dressings are effective in preventing CR-BSI (odds ratio: 
0.43; 95% confidence interval: 0.29‒0.64) and catheter colonization (0.43; 0.36‒0.51).  
We identified an economic evaluation of the use of 2% CHG-impregnated sponge 
dressings and the non-inferiority of dressing changes at three and seven days.15 The authors 
concluded that the major cost avoided by the use of CHG sponge dressings and seven-day 
rather than three-day dressing changes was the increased length of stay of 11 days associated 















value where the cost per CR-BSI was more than $4,400 and the baseline rate of CR-BSI was 
>0.35%.15 
We identified a further RCT of 2% CHG-impregnated gel dressings compared with 
highly adhesive semipermeable dressings or standard semipermeable dressings for the 
prevention of CR-BSI in 1879 patients.4 In the CHG gel group the major catheter-related 
infection rate was 67% lower [0.7 per 1000 vs 2.1 per 1000 catheter-days; hazard ratio (HR): 
0.328; 95% confidence ratio (CI): 0.174‒0.619; P = 0.0006] and the CR-BSI rate 60% lower 
(0.5 per 1000 vs 1.3 per 1000 catheter-days; HR: 0.402; 95% CI: 0.186‒0.868; P = 0.02) than 
with non-chlorhexidine dressings. Decreases were also noted in catheter colonization and skin 
colonization rates at catheter removal. Highly adhesive dressings decreased the detachment 
rate to 64.3% versus 71.9% (P < 0.0001) and the number of dressings per catheter to two (one 
to four) versus three (one to five) (P < 0.0001) but increased skin colonization (P < 0.0001) 
and catheter colonization (HR: 1.650; 95% CI: 1.21‒2.26; P = 0.0016) without influencing 
CR-BSI rates.4  
There have been no direct comparisons of the effectiveness and costs of CHG gel 
dressings impregnated with 2% CHG and 2% CHG sponge dressings. 
Revised recommendation IVAD20  
Consider the use of a 2% chlorhexidine-impregnated sponge or gel dressings in adult patients 
with a central venous catheter as a strategy to reduce catheter-related bloodstream infection. 
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